Evaluating the Therapeutic Potential of Zanubrutinib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma: Evidence to Date

Mantle cell lymphoma (MCL) is an uncommon B-cell non-Hodgkin lymphoma characterized by an aggressive clinical course in the majority of patients. Despite recent improvements in outcomes, MCL remains incurable and a major therapeutic challenge. BTK inhibitors are the preferred treatment option for pa...

Full description

Saved in:
Bibliographic Details
Published in:Onco Targets Ther
Main Authors: Sawalha, Yazeed, Bond, David A, Alinari, Lapo
Format: Artigo
Language:Inglês
Published: Dove 2020
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7351990/
https://ncbi.nlm.nih.gov/pubmed/32753893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S238832
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items